These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 8884811)
1. Modulation of 5-fluorouracil resistance in human colon tumor cell lines by azidothymidine. Findenig G; Mader RM; Fritzer-Szekeres M; Steger GG; Jaeger W; Szekeres T Oncol Res; 1996; 8(5):189-96. PubMed ID: 8884811 [TBL] [Abstract][Full Text] [Related]
2. Azidothymidine and dipyridamole as biochemical response modifiers: synergism with methotrexate and 5-fluorouracil in human colon and pancreatic carcinoma cells. Zhen YS; Taniki T; Weber G Oncol Res; 1992; 4(2):73-8. PubMed ID: 1596584 [TBL] [Abstract][Full Text] [Related]
3. Induction of thymidylate synthase associated with multidrug resistance in human breast and colon cancer cell lines. Chu E; Drake JC; Koeller DM; Zinn S; Jamis-Dow CA; Yeh GC; Allegra CJ Mol Pharmacol; 1991 Feb; 39(2):136-43. PubMed ID: 1704999 [TBL] [Abstract][Full Text] [Related]
4. Mechanisms of acquired chemoresistance to 5-fluorouracil and tomudex: thymidylate synthase dependent and independent networks. Wang W; McLeod HL; Cassidy J; Collie-Duguid ES Cancer Chemother Pharmacol; 2007 May; 59(6):839-45. PubMed ID: 17119966 [TBL] [Abstract][Full Text] [Related]
5. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS 106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Johnston PG; Drake JC; Trepel J; Allegra CJ Cancer Res; 1992 Aug; 52(16):4306-12. PubMed ID: 1643628 [TBL] [Abstract][Full Text] [Related]
6. Thymidylate synthase level as the main predictive parameter for sensitivity to 5-fluorouracil, but not for folate-based thymidylate synthase inhibitors, in 13 nonselected colon cancer cell lines. van Triest B; Pinedo HM; van Hensbergen Y; Smid K; Telleman F; Schoenmakers PS; van der Wilt CL; van Laar JA; Noordhuis P; Jansen G; Peters GJ Clin Cancer Res; 1999 Mar; 5(3):643-54. PubMed ID: 10100718 [TBL] [Abstract][Full Text] [Related]
7. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Okumura K; Shiomi H; Mekata E; Kaizuka M; Endo Y; Kurumi Y; Tani T Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674 [TBL] [Abstract][Full Text] [Related]
8. Cell cycle regulation of the G0/G1 transition in 5-fluorouracil-sensitive and -resistant human colon cancer cell lines. McGinn CJ; Pestalozzi BC; Drake JC; Glennon MC; Kunugi K; Otterson G; Allegra CJ; Johnston PG; Kinsella TJ Cancer J; 2000; 6(4):234-42. PubMed ID: 11038143 [TBL] [Abstract][Full Text] [Related]
9. 5-Fluorouracil enhances azidothymidine cytotoxicity: in vitro, in vivo, and biochemical studies. Brunetti I; Falcone A; Calabresi P; Goulette FA; Darnowski JW Cancer Res; 1990 Jul; 50(13):4026-31. PubMed ID: 2354452 [TBL] [Abstract][Full Text] [Related]
10. Thymidine kinase, thymidylate synthase, and dihydropyrimidine dehydrogenase profiles of cell lines of the National Cancer Institute's Anticancer Drug Screen. Grem JL; Danenberg KD; Behan K; Parr A; Young L; Danenberg PV; Nguyen D; Drake J; Monks A; Allegra CJ Clin Cancer Res; 2001 Apr; 7(4):999-1009. PubMed ID: 11309351 [TBL] [Abstract][Full Text] [Related]
11. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA. Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858 [TBL] [Abstract][Full Text] [Related]
12. Cytotoxic interactions of 5-fluorouracil and nucleoside analogues in vitro. Li YX; Coucke PA; Paschoud N; Mirimanoff RO Anticancer Res; 1997; 17(1A):21-7. PubMed ID: 9066626 [TBL] [Abstract][Full Text] [Related]
13. Interaction of gamma interferon and 5-fluorouracil in the H630 human colon carcinoma cell line. Chu E; Zinn S; Boarman D; Allegra CJ Cancer Res; 1990 Sep; 50(18):5834-40. PubMed ID: 1697502 [TBL] [Abstract][Full Text] [Related]
14. Sensitivity of human, murine, and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Peters GJ; Laurensse E; Leyva A; Lankelma J; Pinedo HM Cancer Res; 1986 Jan; 46(1):20-8. PubMed ID: 2415245 [TBL] [Abstract][Full Text] [Related]
15. Azidothymidine-induced cytotoxicity and incorporation into DNA in the human colon tumor cell line HCT-8 is enhanced by methotrexate in vitro and in vivo. Tosi P; Calabresi P; Goulette FA; Renaud CA; Darnowski JW Cancer Res; 1992 Aug; 52(15):4069-73. PubMed ID: 1638518 [TBL] [Abstract][Full Text] [Related]
16. [Influence on 5-fluorouracil metabolism by combination of interferon-alpha and 5-fluorouracil against human hepatocellular carcinoma xenografts]. Jin CD; Yamamoto T; Nakamura M; Arai I; Kishin R; Xing X; Nagano H; Dono K; Umeshita K; Nakamori S; Sakon M; Monden M Gan To Kagaku Ryoho; 2004 Oct; 31(10):1511-5. PubMed ID: 15508442 [TBL] [Abstract][Full Text] [Related]
17. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil. Matsuoka K; Tsukuda K; Suda M; Kobayashi K; Ota T; Okita A; Watanabe K; Suzuki E; Murakami M; Doihara H; Shimizu N Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960 [TBL] [Abstract][Full Text] [Related]
18. Suppression of replication of multidrug-resistant HIV type 1 variants by combinations of thymidylate synthase inhibitors with zidovudine or stavudine. Gao WY; Johns DG; Tanaka M; Mitsuya H Mol Pharmacol; 1999 Mar; 55(3):535-40. PubMed ID: 10051538 [TBL] [Abstract][Full Text] [Related]
19. Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance. Shin YK; Yoo BC; Chang HJ; Jeon E; Hong SH; Jung MS; Lim SJ; Park JG Cancer Res; 2005 Apr; 65(8):3162-70. PubMed ID: 15833846 [TBL] [Abstract][Full Text] [Related]
20. Dihydropyrimidine dehydrogenase but not thymidylate synthase expression is associated with resistance to 5-fluorouracil in colorectal cancer. Nita ME; Tominaga O; Nagawa H; Tsuruo T; Muto T Hepatogastroenterology; 1998; 45(24):2117-22. PubMed ID: 9951876 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]